
After a blood test, a slightly high cholesterol figure is sometimes enough to trigger a very concrete question: should you make an appointment with a cardiologist to avoid a heart attack or stroke? In a recommendation published on November 19, 2026, the High Authority for Health does not propose a systematic visit to the specialist.
The starting point, in France, remains rather a
global assessment of cardiovascular riskoften constructed in primary care medicine, then adjusted with the patient. The objective is not to multiply examinations “just in case”, but to choose what really changes prevention.
Why is a single number not enough to assess your risk?
The HAS first recalls the weight of these diseases: cardiovascular diseases are the second cause of death in France, with nearly 138,000 deaths per year, and more than a million people hospitalized each year following a cardiovascular accident. Hence the interest in identifying risky situations early, before a first event, but also after a heart attack, a stroke or another established cardiovascular accident.
However, prevention is not limited to cholesterol levels or blood pressure taken in isolation. The risk increases with the accumulation of factors: age, sex, heredity, smoking, alcohol, sedentary lifestyle, unbalanced diet, overweight, diabetes, high blood pressure or hypercholesterolemia. It is this sum of elements which must guide the discussion, as also reminded by the benchmarks for preventing the risk of heart attack and the risk factors for stroke.
In primary prevention, before a first accident, the assessment is based on questioning, personal and family history, possible symptoms, lifestyle habits, clinical examination, blood pressure, body mass index and analyzes such as fasting blood sugar or lipid profile. The SCORE2 score can complete the estimation of the risk of first heart attack or stroke at ten years, but it does not replace clinical analysis and does not apply universally to all ages or profiles.
Cardiologist, ECG, calcium score: when should we go further?
The recommendation concerns several professionals, including general practitioners, cardiologists, diabetologists, pharmacists, nutritionists and tobacco specialists. But its framework is indeed that of first resort care and on a case-by-case basis. In other words, the cardiologist may be necessary in certain situations, but it is not presented as an obligatory step for anyone who wishes to prevent a cardiovascular accident.
The same logic applies to additional examinations. The HAS does not recommend generalizing the ECG, the Doppler ultrasound or the coronary calcium score to all people worried about their heart. These examinations must be discussed according to the risk profile and above all according to a simple question: will their result really change the treatment?
To construct these recommendations, the HAS indicates that it used the GRADE method, which assesses the quality of evidence, the benefit-risk balance and patient preferences. This is an important limit to keep in mind: the text distinguishes what is demonstrated from what is more expertise, and favors results that matter to patients, such as reducing heart attacks, strokes or mortality.
Lifestyle, statins, aspirin: what can we learn from them?
Before talking about medications, HAS emphasizes lifestyle measures. The priorities cited are stopping smoking, physical activity, reducing a sedentary lifestyle and a Mediterranean-style diet. The message is not to change everything overnight, but to support progressive, realistic and sustained changes over time.
When it comes to processing, automatism is not the rule either. For primary prevention, statins can be offered to people with several risk factors, with an expected benefit that is greater as the overall risk is high. In secondary prevention, after a cardiovascular accident, they are strongly recommended to reduce the risk of recurrence and death.
Low-dose aspirin follows a different trajectory. In this recommendation, the HAS considers it effective in secondary prevention, but does not recommend it in primary prevention, because the risk of bleeding can counterbalance the expected benefit. For the patient, the consequence is very concrete: do not add or stop preventive treatment alonebut review the real risk with the professional who ensures monitoring.